2025 Texas sessionsRegular and both called sessions have ended. This index covers House and Senate bills, not resolutions. Statuses come from official reports.

2025 · Regular session · Senate bill

SB1084

SB1084 replaces Texas’s general breast-density notice with a notice tailored to the patient’s mammogram report.

Read bill highlights ↓

Official caption: Relating to certain mammography reports providing required breast density information.

Signed by governorSource-checked explanation published

Official report lists Senate author(s): Campbell. This does not identify sponsors or amendment drafters.

Report an error ↗

Bill explanation published · Version and amendment review scope is stated below · Individual amendment records may not be separately annotated.

Bill highlights

Selected points from the published explanation. Follow each point to its source-linked context; conditions and limits may matter.

SB1084 replaces Texas’s general breast-density notice with a notice tailored to the patient’s mammogram report.
A report describing breasts as “almost entirely fatty” or having “scattered areas of fibroglandular density” requires the not-dense statement.
The facility must also retain the notice that a report will be sent to the patient and physician and that the patient should contact the physician with questions or concerns.
The existing section’s legal limits remain unchanged: it does not create a cause of action or a standard of care, obligation or duty that supplies the basis for one, and the information required by the section or evidence of its violation is not admissible in a civil, judicial or administrative proceeding.

Read the full explanation ↓

What does it do?

SB1084 replaces Texas’s general breast-density notice with a notice tailored to the patient’s mammogram report. FDA-certified mammography facilities, and facilities certified by an FDA-approved certification agency, must be aware of and comply with applicable federal and state dense-breast reporting requirements and provide the specified notices when a mammogram is completed. Signed June 20, 2025, the law took effect September 1, 2025. Final law; Official history.

A report describing breasts as “almost entirely fatty” or having “scattered areas of fibroglandular density” requires the not-dense statement. A report describing breasts as “heterogeneously dense, which may obscure small masses” or “extremely dense, which lowers the sensitivity of mammography” requires the dense statement. Both notices explain that dense tissue makes cancer harder to find on a mammogram and raises the risk of developing breast cancer, and both advise discussing individual risks and circumstances with a health-care provider. The dense notice additionally says that, for some people with dense tissue, other imaging tests may help find cancers. These are required notification messages, not a finding that a particular patient has cancer. Final law, section 1.

The facility must also retain the notice that a report will be sent to the patient and physician and that the patient should contact the physician with questions or concerns. SB1084 changes information supplied to patients; it does not itself require every patient with dense tissue to undergo additional imaging or create an insurance-coverage mandate. Final law.

The existing section’s legal limits remain unchanged: it does not create a cause of action or a standard of care, obligation or duty that supplies the basis for one, and the information required by the section or evidence of its violation is not admissible in a civil, judicial or administrative proceeding. This is the scope of this particular section, not a claim of blanket immunity from other laws. Previous section 86.013, subsections (b)–(c); Final law.

What changed along the way?

The previous Texas notice conditionally discussed dense tissue plus other identified risk factors and possible supplemental screening, while describing density as a common condition. The new text replaces those paragraphs with separate dense/not-dense messages but retains the report-and-questions notice. The operative provisions are unchanged across the introduced, Senate committee, engrossed, House committee and enrolled texts. No amendments are listed in the official amendment index. Previous section 86.013; Introduced bill; All versions; Amendment index; Final law.

The new Texas messages follow the federal dense/not-dense notification approach. FDA states that enforcement of its revised mammography regulations, including density notification, began September 10, 2024. SB1084 therefore should not be described as the first nationwide density-notification requirement, or as postponing federal compliance until Texas’s September 2025 effective date. FDA’s explanation of the federal rule; Final law.

For the full amendment record, open the official amendment index.

Official bill versions

Compare the published text versions in the official text index. A change is not attributed to a specific amendment here without a verified record.

Who could benefit—and who could bear the costs?

Patients receive a notice that directly identifies whether their reported breast tissue is dense, supporting a more specific conversation with their clinician. Covered facilities must use the applicable wording and comply with the reporting requirements. The statute’s notice does not promise that additional imaging will benefit every patient, and the bill does not estimate improved detection or survival rates. Final law; FDA’s explanation of the federal rule.

The March 10 and May 14 fiscal notes anticipate no significant state or local fiscal implication and assume costs can be absorbed using existing resources. They do not quantify a patient’s imaging charges, insurance coverage or a private facility’s costs. This is not an appropriation or a promise of free additional screening. Introduced fiscal note; Engrossed fiscal note; Final law.

Official sources

Catalog report retrieved 2026-10-25. Check the official record for corrections or later changes.